These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2003863)

  • 1. Antibodies against galactosyl (alpha 1----3) galactose in connective tissue diseases.
    Gabrielli A; Leoni P; Danieli G; Herrmann K; Krieg T; Wieslander J
    Arthritis Rheum; 1991 Mar; 34(3):375-6. PubMed ID: 2003863
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.
    Gabrielli A; Candela M; Ricciatti AM; Caniglia ML; Wieslander J
    Clin Exp Immunol; 1991 Dec; 86(3):367-73. PubMed ID: 1721011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in laboratory tests of connective tissue diseases].
    Yamane K; Kato S; Sakauchi M
    Rinsho Byori; 1989 Dec; 37(12):1311-6. PubMed ID: 2614963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes.
    Kasturi KN; Hatakeyama A; Spiera H; Bona CA
    J Exp Med; 1995 Mar; 181(3):1027-36. PubMed ID: 7532674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.
    Mouritsen S; Demant E; Permin H; Wiik A
    Clin Exp Immunol; 1986 Oct; 66(1):68-76. PubMed ID: 3802575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against terminal galactosyl (alpha 1-3) galactose epitopes in systemic sclerosis (scleroderma).
    Gabrielli A; Candela M; Pisani E; Hermann K; Wieslander J; Danieli G; Krieg T
    Clin Exp Rheumatol; 1992; 10(1):31-6. PubMed ID: 1372543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serology in patients with scleroderma].
    Ullman S; Halberg P; Høier-Madsen M; Kang L; Konstantinov K; Pedersen K; Rasmussen E; Wiik A
    Ugeskr Laeger; 1993 Feb; 155(7):472-6. PubMed ID: 8465453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.
    Rosenbaum J; Pottinger BE; Woo P; Black CM; Loizou S; Byron MA; Pearson JD
    Clin Exp Immunol; 1988 Jun; 72(3):450-6. PubMed ID: 3168322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue diseases and bovine collagen implants.
    McCoy JP; Waldinger TP; Cohen KA; Schade W; Siegle R; Hamilton TA; Swanson NA
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 1):315-8. PubMed ID: 3819066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).
    Valentini G
    Autoimmun Rev; 2015 Mar; 14(3):210-3. PubMed ID: 25461837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue diseases: New criteria improve recognition of early systemic sclerosis.
    Asano Y; Sato S
    Nat Rev Rheumatol; 2015 Jan; 11(1):3-4. PubMed ID: 25385415
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens.
    Mimori T
    Intern Med; 1999 Jul; 38(7):523-32. PubMed ID: 10435356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of antihistone and anti-bicatenary RNA antibodies in connective tissue diseases using immunoenzyme technic].
    Gioud M; Ait Kaci A; Sepetjan M; Monier JC
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):385-91. PubMed ID: 7100807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity and the skin.
    Kumar V; Beutner EH; Chorzelski TP
    Concepts Immunopathol; 1985; 1():318-53. PubMed ID: 3916406
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients.
    Hoffman RW; Sharp GC; Irvin WS; Anderson SK; Hewett JE; Pandey JP
    Arthritis Rheum; 1991 Apr; 34(4):453-8. PubMed ID: 1826425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antinuclear autoantibodies].
    Röther E; Peter HH
    Internist (Berl); 1995 Mar; 36(3):277-81. PubMed ID: 7737821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.